Grant: Discovery Grants Program - Individual
Université de Sherbrooke
$27,000.00
Regulation of MHC class II genes and molecules
FY 2012-13
Summary
My research program is focused on fundamental molecular mechanisms controlling the expression of Major histocompatibility class II (MHC-II) genes and the intracellular transport of MHC-II molecules. MHC-II molecules serve as antigen presenting molecules for CD4-positive T cells, which play a central role for the adaptive immune response, since they modulate most of the immune reactions, such as activation of B cell, macrophages and CD8-positive cytotoxic T cells. Both MHC-II genes and molecules are subject to multiple levels of control, which are essential for the correct function of the immune response and thus present a very interesting and relevant model system for the study of multi-layered regulatory circuits.
The majority of positive and negative regulatory mechanisms of MHC-II gene expression are orchestrated directly or indirectly by the MHC-II transactivator CIITA. CIITA is a large non-DNA-binding transcriptional activator and its mode of action is only partially understood. We have found recently that the extreme N-terminal end of CIITA is both necessary for degradation and transcriptional activation. I propose to identify and characterize ubiquitin ligases involved in the N-terminal turnover of CIITA and other CIITA-associated proteins via a proteomic approach. Mechanisms involved in CIITA turnover and MHC-II gene activation will be analyzed in a time-resolved kinetic experiments.
MARCH protein ubiquitin ligases have emerged as a novel class of immunomodulators. We have shown recently that MARCH1 is essential for the IL-10-induced down-regulation of MHC-II molecules expression in monocytes. The mode of action of MARCH proteins and their regulation is still only very poorly understood. I propose to study the regulation of the MARCH1 gene.
Program
Discovery Grants Program - Individual
Recipient
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data
As published
Application id
262845-2010
Name nom
Steimle, Viktor
Department département
Biologie
Organization id
68
Institution établissement
Université de Sherbrooke
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2012
Competition year année de concours
2010
Award amount
27000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
1501
Committee name en
Genes, Cells and Molecules
Committee name fr
Gènes, cellules et molécules
Area of application code
1200
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Advancement of knowledge
Area of application fr
Avancement des connaissances
Research subject code
5300
Research subject group en
Molecular biology
Research subject group fr
Biologie moléculaire
Research subject en
Molecular biology
Research subject fr
Biologie moléculaire
Partie
3
Nb partie
5
Application title
Regulation of MHC class II genes and molecules
Keyword
NSERC
Application summary
My research program is focused on fundamental molecular mechanisms controlling the expression of Major histocompatibility class II (MHC-II) genes and the intracellular transport of MHC-II molecules. MHC-II molecules serve as antigen presenting molecules for CD4-positive T cells, which play a central role for the adaptive immune response, since they modulate most of the immune reactions, such as activation of B cell, macrophages and CD8-positive cytotoxic T cells. Both MHC-II genes and molecules are subject to multiple levels of control, which are essential for the correct function of the immune response and thus present a very interesting and relevant model system for the study of multi-layered regulatory circuits.
The majority of positive and negative regulatory mechanisms of MHC-II gene expression are orchestrated directly or indirectly by the MHC-II transactivator CIITA. CIITA is a large non-DNA-binding transcriptional activator and its mode of action is only partially understood. We have found recently that the extreme N-terminal end of CIITA is both necessary for degradation and transcriptional activation. I propose to identify and characterize ubiquitin ligases involved in the N-terminal turnover of CIITA and other CIITA-associated proteins via a proteomic approach. Mechanisms involved in CIITA turnover and MHC-II gene activation will be analyzed in a time-resolved kinetic experiments.
MARCH protein ubiquitin ligases have emerged as a novel class of immunomodulators. We have shown recently that MARCH1 is essential for the IL-10-induced down-regulation of MHC-II molecules expression in monocytes. The mode of action of MARCH proteins and their regulation is still only very poorly understood. I propose to study the regulation of the MARCH1 gene.